Hiroshi Moritake

1.8k total citations
80 papers, 874 citations indexed

About

Hiroshi Moritake is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Hiroshi Moritake has authored 80 papers receiving a total of 874 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Hematology, 25 papers in Molecular Biology and 20 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Hiroshi Moritake's work include Acute Myeloid Leukemia Research (20 papers), Acute Lymphoblastic Leukemia research (16 papers) and Hematopoietic Stem Cell Transplantation (14 papers). Hiroshi Moritake is often cited by papers focused on Acute Myeloid Leukemia Research (20 papers), Acute Lymphoblastic Leukemia research (16 papers) and Hematopoietic Stem Cell Transplantation (14 papers). Hiroshi Moritake collaborates with scholars based in Japan, United States and Singapore. Hiroshi Moritake's co-authors include Hiroyuki Nunoi, Tohru Sugimoto, Ai Yamada, Megumi Funakoshi‐Tago, Evan Parganas, James N. Ihle, S. William Pelletier, Hiroshi Kuroda, Mariko Kinoshita and Hideki Nakayama and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Hiroshi Moritake

75 papers receiving 864 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroshi Moritake Japan 17 301 301 181 148 119 80 874
Robin E. Norris United States 14 325 1.1× 121 0.4× 211 1.2× 137 0.9× 149 1.3× 46 694
Ivan de Kouchkovsky United States 8 582 1.9× 561 1.9× 228 1.3× 119 0.8× 125 1.1× 31 1.2k
Simon Bomken United Kingdom 13 376 1.2× 234 0.8× 366 2.0× 202 1.4× 44 0.4× 32 964
Yanming Zhang China 13 295 1.0× 287 1.0× 316 1.7× 85 0.6× 59 0.5× 58 862
Nalini Jayaprakash United States 16 226 0.8× 141 0.5× 197 1.1× 155 1.0× 256 2.2× 21 825
Kenneth B. DeSantes United States 16 275 0.9× 322 1.1× 354 2.0× 124 0.8× 82 0.7× 32 1.1k
J. L. Pico France 14 231 0.8× 306 1.0× 211 1.2× 174 1.2× 107 0.9× 23 894
Jacob Baram United States 12 321 1.1× 203 0.7× 121 0.7× 329 2.2× 66 0.6× 16 1.1k
Sébastien Malinge United States 17 631 2.1× 611 2.0× 188 1.0× 323 2.2× 137 1.2× 33 1.4k

Countries citing papers authored by Hiroshi Moritake

Since Specialization
Citations

This map shows the geographic impact of Hiroshi Moritake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Moritake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Moritake more than expected).

Fields of papers citing papers by Hiroshi Moritake

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Moritake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Moritake. The network helps show where Hiroshi Moritake may publish in the future.

Co-authorship network of co-authors of Hiroshi Moritake

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Moritake. A scholar is included among the top collaborators of Hiroshi Moritake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Moritake. Hiroshi Moritake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goto, Hironori, Souichi Suenobu, Yuhki Koga, et al.. (2025). H3K27me3 and HOXA9 expression predict prognosis in pediatric acute myeloid leukemia: an epigenetic-transcriptional correlation study. SHILAP Revista de lepidopterología. 4.
2.
Kato, Shota, Kentaro Nakashima, Genki Yamato, et al.. (2024). Azacitidine treatment for myeloid leukemia associated with Down syndrome: A nationwide retrospective study in Japan. Pediatric Blood & Cancer. 71(10). e31244–e31244.
3.
Yamada, Ai, et al.. (2024). CFAP43 variant in persistent respiratory symptoms after hematopoietic cell transplantation. Human Genome Variation. 11(1). 41–41.
4.
Yamada, Ai, et al.. (2023). [Successful treatment of eltrombopag following immunosuppressive therapy in pediatric aplastic anemia].. PubMed. 64(8). 741–745. 1 indexed citations
5.
Makino, Shinya, et al.. (2023). Novel splice site variant of TMEM38B in osteogenesis imperfecta type XIV. Human Genome Variation. 10(1). 25–25. 3 indexed citations
6.
Kawano, Takafumi, Yusuke Saito, Shun Onishi, et al.. (2021). Malignant perivascular epithelioid cell neoplasm in the liver: report of a pediatric case. SHILAP Revista de lepidopterología. 7(1). 212–212. 7 indexed citations
7.
Moritake, Hiroshi, Shiro Tanaka, Takako Miyamura, et al.. (2020). The outcomes of relapsed acute myeloid leukemia in children: Results from the Japanese Pediatric Leukemia/Lymphoma Study Group AML‐05R study. Pediatric Blood & Cancer. 68(1). e28736–e28736. 12 indexed citations
8.
Miyamura, Takako, Hiroshi Moritake, Hideki Nakayama, et al.. (2019). Clinical and biological features of paediatric acute myeloid leukaemia (AML) with primary induction failure in the Japanese Paediatric Leukaemia/Lymphoma Study Group AML‐05 study. British Journal of Haematology. 185(2). 284–288. 15 indexed citations
9.
Nakayama, Hideki, Daisuke Tomizawa, Shiro Tanaka, et al.. (2017). Fludarabine, cytarabine, granulocyte colony‐stimulating factor and idarubicin for relapsed childhood acute myeloid leukemia. Pediatrics International. 59(10). 1046–1052. 6 indexed citations
10.
Ikeda, Toshio, Rie Nagano, Hiroshi Moritake, et al.. (2016). TBCD may be a causal gene in progressive neurodegenerative encephalopathy with atypical infantile spinal muscular atrophy. Journal of Human Genetics. 62(4). 473–480. 13 indexed citations
11.
Inagaki, Jiro, Hiroshi Moritake, Takuro Nishikawa, et al.. (2015). Long-Term Morbidity and Mortality in Children with Chronic Graft-versus-Host Disease Classified by National Institutes of Health Consensus Criteria after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 21(11). 1973–1980. 27 indexed citations
12.
Moritake, Hiroshi, Yujiro Asada, Hiroyuki Komatsu, et al.. (2015). Analysis of the molecular mechanism underlying bone marrow necrosis with acute lymphoblastic leukemia. International Journal of Hematology. 102(3). 349–356. 11 indexed citations
13.
Nakayama, Hideki, Ken Tabuchi, Akio Tawa, et al.. (2014). Outcome of children with relapsed acute myeloid leukemia following initial therapy under the AML99 protocol. International Journal of Hematology. 100(2). 171–179. 29 indexed citations
14.
Yamada, Nami, Shunsuke Noguchi, Hiroshi Moritake, et al.. (2013). Ewing Sarcoma Cells Secrete EWS/Fli-1 Fusion mRNA via Microvesicles. PLoS ONE. 8(10). e77416–e77416. 22 indexed citations
15.
Tomizawa, Daisuke, Akio Tawa, Tomoyuki Watanabe, et al.. (2013). Appropriate dose reduction in induction therapy is essential for the treatment of infants with acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group. International Journal of Hematology. 98(5). 578–588. 37 indexed citations
16.
17.
Mizoue, Tetsuya, et al.. (2004). Residential Proximity to High-Voltage Power Lines and Risk of Childhood Hematological Malignancies. Journal of Epidemiology. 14(4). 118–123. 9 indexed citations
18.
Manabe, Atsushi, Yasuhiro Ebihara, Hiroshi Yagasaki, et al.. (2004). Viral Infections in Juvenile Myelomonocytic Leukemia: Prevalence and Clinical Implications. Journal of Pediatric Hematology/Oncology. 26(10). 636–641. 24 indexed citations
19.
Moritake, Hiroshi, Yoshihiro Horii, Hiroshi Kuroda, & Tohru Sugimoto. (2001). Analysis of PTEN/MMAC1 alteration in neuroblastoma. Cancer Genetics and Cytogenetics. 125(2). 151–155. 18 indexed citations
20.
Moritake, Hiroshi, et al.. (1998). Donor leukocyte infusion after allogeneic bone marrow transplantation was not effective for relapsed rhabdomyosarcoma. Bone Marrow Transplantation. 21(7). 725–726. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robin E. Norris Breakdown of academic impact, for papers by Ivan de Kouchkovsky Breakdown of academic impact, for papers by Simon Bomken Breakdown of academic impact, for papers by Yanming Zhang Breakdown of academic impact, for papers by Nalini Jayaprakash Breakdown of academic impact, for papers by Kenneth B. DeSantes Breakdown of academic impact, for papers by J. L. Pico Breakdown of academic impact, for papers by Jacob Baram Breakdown of academic impact, for papers by Sébastien Malinge
Rankless by CCL
2026